MRI-guided attenuation correction in whole-body PET/MR: Assessment of the effect of bone attenuation

Annals of Nuclear Medicine

Volumn 27, Issue 2, 2013, Pages 152-162

  Akbarzadeh, A ^a,b   Ay, M R ^a,b,c   Ahmadian, A ^a,b   Riahi Alam, N ^a   Zaidi, H ^d,e,f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Attenuation correction; PET CT; PET MRI; Quantification; Tissue classification

Indexed keywords

ACCURACY; ARTICLE; ATTENUATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL BONE; HUMAN; LUNG; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE;

BONE AND BONES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 84880698681     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0667-3     Document Type: Article

References (42)

1. Schmidt GP, Schmid R, Hahn K, Reiser MF. Whole-body MRI and PET/CT in tumor diagnosis. Der Radiologe. 2004;44:1079-87.
2. Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res. 2006;11:58-65.
3. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290:3199-206.
4. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nuc Med Mol Imaging. 2009;36(Suppl 1):S113-20.
5. Heiss W-D. The potential of PET/MR for brain imaging. Eur J Nuc Med Mol Imaging. 2009;36(Suppl 1):S105-12.
6. Zaidi H, Del Guerra A. An outlook on future design of hybrid PET/MRI systems. Med Phys. 2011;38:5667.
7. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med. 2003;33:166-79.
8. Ay MR, Shirmohammad M, Sarkar S, Rahmim A, Zaidi H. Comparative assessment of energy-mapping approaches in CT-based attenuation correction for PET. Mol Imaging Biol. 2011;13:187-98.
9. Zaidi H. Is MRI-guided attenuation correction a viable option for dual-modality PET/MR imaging? Radiology. 2007;244:639-42.
10. Hofmann M, Pichler B, Schölkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nuc Med Mol Imaging. 2009;36(Suppl 1):S93-104.
11. Schulz V, Torres-Espallardo I, Renisch S, Hu Z, Ojha N, Börnert P, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging. 2011;38:138-52.
12. Zaidi H, Ojha N, Morich M, Griesmer J, Hu Z, Maniawski P, et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol. 2011;56:3091-106.
13. Martinez-Moller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520-6.
14. Keereman V, Fierens Y, Broux T, De Deene Y, Lonneux M, Vandenberghe S. MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences. J Nucl Med. 2010;51:812-8.
15. Catana C, van der Kouwe A, Benner T, Michel CJ, Hamm M, Fenchel M, et al. Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype. J Nucl Med. 2010;51:1431-8.
16. Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, et al. MRI-based attenuation correction for hybrid PET/MRI systems: A 4-class tissue segmentation technique using a combined Ultrashort-Echo-Time/Dixon MRI sequence. J Nucl Med. 2012;53:796-804.
17. Johansson A, Karlsson M, Nyholm T. CT substitute derived from MRI sequences with ultrashort echo time. Med Phys. 2011;38:2708-14.
18. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25:2046-53.
19. Visvikis D, Costa DC, Croasdale I, Lonn AH, Bomanji J, Gacinovic S, et al. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET. Eur J Nucl Med Mol Imaging. 2003;30:344-53.
20. Hu Z, Ojha N, Renisch S, Schulz V, Torres I, Pal D, et al. MR-based attenuation correction for a whole-body sequential PET/MR system. In: M11-6, editor. IEEE nuclear science symposium and medical imaging conference. 25-31 October 2009, Orlando (FL), USA: IEEE, 2009, pp. 3508-12.
21. Zaidi H, Montandon M-L, Slosman DO. Magnetic resonance imaging-guided attenuation and scatter corrections in three-dimensional brain positron emission tomography. Med Phys. 2003;30:937-48.
22. Keereman V, Holen RV, Mollet P, Vandenberghe S. The effect of errors in segmented attenuation maps on PET quantification. Med Phys. 2011;38:6010-9.
23. Segars WP, Mahesh M, Beck TJ, Frey EC, Tsui BMW. Realistic CT simulation using the 4D XCAT phantom. Med Phys. 2008;35:3800-8.
24. Segars WP, Sturgeon G, Mendonca S, Grimes J, Tsui BM. 4D XCAT phantom for multimodality imaging research. Med Phys. 2010;37:4902-15.
25. Raylman RR, Kison PV, Wahl RL. Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med. 1999;26:39-45.
26. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847-50.
27. Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431-4.
28. Valk PE, Delbeke D, Bailey DL, editors. Positron Emission Tomography: Clinical Practice. Chapter 5 ed. London: Springer; 2006
29. Thielemans K, Tsoumpas C, Mustafovic S, Beisel T, Aguiar P, Dikaios N, et al. STIR: software for tomographic image reconstruction release 2. Phys Med Biol. 2012;57:867-83.
30. Carney JP, Townsend DW, Rappoport V, Bendriem B. Method for transforming CT images for attenuation correction in PET/CT imaging. Med Phys. 2006;33:976-83.
31. Yoo TS, Ackerman MJ, Lorensen WE, Schroeder W, Chalana V, Aylward S, et al. Engineering and algorithm design for an image processing Api: a technical report on ITK-the Insight Toolkit. Stud Health Technol Inform. 2002;85:586-92.
32. Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008;49:1804-8.
33. Hofmann M, Bezrukov I, Mantlik F, Aschoff P, Steinke F, Beyer T, et al. MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and Atlas-based methods. J Nucl Med. 2011;52:1392-9.
34. Samarin A, Burger C, Wollenweber SD, Crook DW, Burger IA, Schmid DT, et al. PET/MR imaging of bone lesions - implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging. 2012;39:1154-60.
35. Akbarzadeh A, Ay MR, Ahmadian A, Riahi Alam N, Zaidi H. Impact of using different tissue classes on the accuracy of MR-based attenuation correction in PET-MRI. IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 2011, pp. 2524-30.
36. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48:214-20.
37. Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007;68:377-82.
38. Hubner KF, Buonocore E, Gould HR, Thie J, Smith GT, Stephens S, et al. Differentiating benign from malignant lung lesions using " quantitative" parameters of FDG PET images. Clin Nucl Med. 1996;21:941-9.
39. Nguyen NC, Kaushik A, Wolverson MK, Osman MM. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Acta Oncol. 2011;50:670-7.
40. Ay M, Zaidi H. Computed Tomography-based attenuation correction in neurological positron emission tomography: evaluation of the effect of X-ray tube voltage on quantitative analysis. Nucl Med Commun. 2006;27:339-46.
41. Ay M, Zaidi H. Assessment of errors caused by x-ray scatter and use of contrast medium when using CT-based attenuation correction in PET. Eur J Nucl Med Mol Imaging. 2006;33:1301-13.
42. Teimourian B, Ay MR, Zafarghandi MS, Ghafarian P, Ghadiri H, Zaidi H. A novel energy mapping approach for CT-based attenuation correction in PET. Med Phys. 2012;39:2078-89.